Results 221 to 230 of about 29,283 (270)

Circulating tumor DNA and prognosis in gastric cancer patients undergoing surgery: meta-analysis and trial sequential analysis. [PDF]

Front Oncol
Bian J, Liu J.
europepmc   +1 more source

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC. [PDF]

Clin Cancer Res
Chauhan PS, Pachynski RK, Maher CA, Chaudhuri AA.   +3 more
europepmc   +1 more source

CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients. [PDF]

J Neurooncol
Arjuna S, Pirhoushiaran M, Bueno A, Sanchez-Espitia A, Tavakkol E, Khalaj K, Shah M, Wang I, Balar AP, Dono A, Duose D, Nguyen S, Kamali A, Luthra R, Patel CB, Prabhu SS, Lang FF, Esquenazi Y, Ballester LY.   +18 more
europepmc   +1 more source

Estimating (stage-)sojourn time for multiple cancer-sites: literature review and structured elicitation of expert beliefs

Jankovic D, Palmer S, Callister ME, Lyratzopoulos G, Dias S, Welton NJ, Payne K, Soares MO.   +7 more
europepmc   +1 more source

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial. [PDF]

Clin Cancer Res
Bianchini G, Malorni L, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Colleoni M, Allegrini G, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Adamo V, Romagnoli E, Valerio MR, Cinieri S, Benelli M, Callari M, Valsecchi D, Castelletti D, Grasso D, Fenderico N, Arpino G, De Laurentiis M.   +27 more
europepmc   +1 more source

Role of ctDNA in Breast Cancer [PDF]

Cancers, 2022
Breast cancer is currently classified by immunohistochemistry. However, technological advances in the detection of circulating tumor DNA (ctDNA) have made new options available for diagnosis, classification, biological knowledge, and treatment selection.
Eudald Felip, Mireia Margéli Vila, Felip Eudald   +2 more
exaly   +9 more sources

The Role of ctDNA in Gastric Cancer

Cancers, 2022
Circulating tumour DNA (ctDNA) has potential applications in gastric cancer (GC) with respect to screening, the detection of minimal residual disease (MRD) following curative surgery, and in the advanced disease setting for treatment decision making and therapeutic monitoring. It can provide a less invasive and convenient method to capture the tumoural
Naureen Starling, Elizabeth Cartwright, Starling Naureen   +2 more
exaly   +5 more sources

Liquid Biopsy, ctDNA Diagnosis through NGS

Life, 2021
Liquid biopsy with circulating tumor DNA (ctDNA) profiling by next-generation sequencing holds great promise to revolutionize clinical oncology. It relies on the basis that ctDNA represents the real-time status of the tumor genome which contains ...
Rongqin Ke, Chi-Meng Tzeng
exaly   +2 more sources